Rapid Fire Marketing (RPDM) 10-K 13 Apr 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 25, 2015	Jun. 30, 2014
Document And Entity Information [Abstract]
Entity Registrant Name	RAPID FIRE MARKETING, INC.
Entity Central Index Key	859917
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filer	No
Entity's Reporting Status Current	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$6,641,624
Entity Common Stock, Shares Outstanding		6,556,071,515
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Assets:
Cash and cash equivalents	$4,430	$2,351
Accrued interest	52,179	16,744
Accounts receivable
Inventory	40,373	130,814
Deposit on inventory	104,000	104,000
Prepaid expense	22,500
Current assets	223,482	253,909
Total assets	223,482	253,909
Current liabilities
Accounts payable and accrued liabilities	670,959	305,680
Convertible notes payable, net discount of $25,767 and $0	112,733	23,500
Derivative liabilities	177,323
Current liabilities	961,015	329,180
Total liabilities	961,015	329,180
Commitments and contingencies
Stockholders' Equity (Deficit):
Preferred Stock		23,790
Common Stock,$0.001 par value 20,000,000,000 shares authorized, 4,609,208,217 and 2,789,513,042 shares issued and outstanding at December 31, 2014 and December 31, 2013, respectively. 500,000,000 shares reserved for issuance at December 31, 2014	4,960,208	2,789,513
Stock to be issued	1,014,906	10,000
Additional paid-in capital	22,094,591	14,991,494
Stock subscription receivable	-5,516,000	-1,116,000
Deferred stock compensation		-80,000
Accumulated deficit	-23,310,033	-16,694,068
Total stockholders' equity (deficit)	-737,533	-75,271
Total liabilities and stockholders' equity (deficit)	223,482	253,909
Series A1 Convertible Preferred stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock	2,790	7,790
Series A2 Convertible Preferred stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock
Series B Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock	16,000	16,000
Series C Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock	$5

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument, Unamortized Discount	$25,767	$0
Preferred Stock, Shares Authorized		90,000,000
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	20,000,000,000	20,000,000,000
Common Stock, Shares Issued	4,609,208,217	2,789,513,042
Common Stock, Shares Outstanding	4,609,208,217	2,789,513,042
Series A1 Convertible Preferred stock [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	25,000,000	25,000,000
Preferred Stock, Shares Issued	2,790,000	7,790,000
Preferred Stock, Shares Outstanding	2,790,000	7,790,000
Series A2 Convertible Preferred stock [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	300	300
Preferred Stock, Shares Issued	125	150
Preferred Stock, Shares Outstanding	125	150
Series B Preferred Stock [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	16,000,000	16,000,000
Preferred Stock, Shares Issued	16,000,000	16,000,000
Preferred Stock, Shares Outstanding	16,000,000	16,000,000
Series C Preferred Stock [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	5,000	5,000
Preferred Stock, Shares Issued	5,000	0
Preferred Stock, Shares Outstanding	5,000	0

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Sales	$4,563	$21,834
Costs of sales	92,456	7,525
Gross profit (loss)	-87,893	14,309
Operating expenses:
Sales and marketing	178,720	107,029
General and administrative	854,214	538,782
Research and development	40,625	110,175
Stock for services	254,737	2,490,218
Total operating expenses	1,328,296	3,246,204
Loss from operations	-1,416,189	-3,231,895
Other income (expense)
Interest income	45,992	14,591
Interest expense	-636,789	-126,814
Day one charge and change in fair value of derivative liablities	-130,155
Loss on common shares issued	-4,478,824	-424,741
Total other income (expense)	-5,199,776	-536,964
Net loss before income taxes	-6,615,965	-3,768,859
Provision for income taxes
Net loss	($6,615,965)	($3,768,859)
Basic net loss per share	$0	$0
Diluted net loss per share	$0	$0
Basic weighted average number of shares of common stock outstanding	4,480,344,580	2,169,422,459
Diluted weighted average number of shares of common stock outstanding	4,480,344,580	2,169,422,459

Statement_of_Stockholders_Equi

Statement of Stockholders' Equity (USD $)	Series A1 Preferred Stock [Member]	Series A2 Preferred Stock [Member]	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Shares To Be Issued [Member]	Stock Subscription Receivable [Member]	Deferred Stock Compensation [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2012	$10,790				$1,575,114	$12,686,416	$571,518	($1,450,000)	($40,000)	($12,925,209)	$428,629
Balance, shares at Dec. 31, 2012	10,790,000	150			1,575,113,736
Common stock issued for services and stock based compensation					150,000	288,333			-40,000		398,333
Common stock issued for services and stock based compensation, shares					150,000,000
Conversion of preferred stock into common stock	-3,000				90,000	-87,000
Conversion of preferred stock into common stock, shares	-3,000,000				90,000,000
Preferred stock issued for cash								334,000			334,000
Preferred stock issued to Chief Executive Officer			16,000			2,075,885					2,091,885
Preferred stock issued to Chief Executive Officer, shares			16,000,000
Common Stock issued to Ironridge Global IV LTD					974,399	27,860	-561,518				440,741
Common Stock issued to Ironridge Global IV LTD, shares					974,399,306
Net loss										-3,768,859	-3,768,859
Balance at Dec. 31, 2013	7,790	150	16,000		2,789,513	14,991,494	10,000	-116,000	-80,000	-16,694,068	-75,271
Balane, shares at Dec. 31, 2013	7,790,000		16,000,000		2,789,513,042
Conversion of Series A1 preferred stock into common stock	-5,000				150,000	-145,000
Conversion of Series A1 preferred stock into common stock, shares	-5,000,000				150,000,000
Conversion of Series A2 preferred stock into common stock					1,435,738	2,173,180	869,906				4,478,824
Conversion of Series A2 preferred stock into common stock, shares		-25			1,435,738,562
Common stock issued for services and stock based compensation					151,754	22,983	135,000		80,000		389,737
Common stock issued for services and stock based compensation, shares					151,754,386
Common stock issued for convertible notes					410,985	-305,985					105,000
Common stock issued for convertible notes, shares					410,984,849
Reclass of derivative liability upon conversion of corresponding note						170,332					170,332
Preferred Stock issued for Cash				5		4,999,995		-4,400,000			600,000
Preferred Stock issued for Cash, shares				5,000
Common Stock issued to Ironridge Global IV LTD					135,000
Common Stock issued to Ironridge Global IV LTD, shares					50,000,000
Common stock issued for financing					82,218	127,592					209,810
Common stock issued for financing, shares					82,217,378
Common stock returned from prior management					-60,000	60,000
Common stock returned from prior management, shares					-60,000,000
Net loss										-6,615,965	-6,615,965
Balance at Dec. 31, 2014	$2,790		$16,000	$5	$4,960,208	$22,094,591	$1,014,906	($5,516,000)		($23,310,033)	($737,533)
Balane, shares at Dec. 31, 2014	2,790,000	125	16,000,000	5,000	4,960,208,217

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	($6,615,965)	($3,768,859)
Adjustments to reconcile net loss to net cash used in operating activities:
Day one charge and loss on change in fair market value of derivative liabilities	130,155
Common stock issued for services and stock based compensation	389,737	398,333
Series B preferred stock issued for services		2,091,885
Fair market value of common stock issued in connection with Series A preferred stock dividends	4,478,824
Amortization of discount on convertible notes payable	194,233
On issuance discount on convertible notes payable	10,000
Loss on shares issued in excess of liabilities settled		424,741
Changes in operating assets and liabilities:
Accrued interest receivable	-35,435	-12,732
Prepaid expenses	-22,500	182,904
Inventory	90,441	14,712
Deposit on inventory		110,175
Other assets	209,810
Accounts payable and accrued liabilities	447,779	199,970
Net cash used in operating activities	-722,921	-358,871
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable	125,000	9,500
Proceeds received from stock subscription	600,000	350,000
Net cash provided by financing activities	725,000	359,500
Change in cash and cash equivalents	2,079	629
Cash and cash equivalents, beginning of period	2,351	1,722
Cash and cash equivalents, end of period	4,430	2,351
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities:
Conversion of notes payable to common stock	105,000
Conversion of preferred stock into common stock	5,000	3,000
Conversion of accounts payable into convertible note	82,500
Issuance of common stock accounted for as deferred offering costs	209,810
Increase in subscription receivable	5,000,000
Discount on convertible notes payable	217,500
Issuance of common stock accounted for as a prepaid	$135,000

Organization_and_Description_o

Organization and Description of Business	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Note 1 – Organization and Description of Business
	Organization
	Rapid Fire Marketing, Inc. (the “Company” or “RFMK”) was incorporated under the laws of the state of Delaware in 1989 as G.D.E. Search Corporation. In 2001, the Company changed its name to N-Vision Technology. In July 2007, the Company changed its name to Rapid Fire Marketing, Inc.
	Description of Business
	The Company is a developer and reseller of herbal vaporizers. The core strategy is to maximize revenues in the rapidly expanding vaporizer industry. The Company currently sells the CANNAcig and Cumulus personal vapor inhalers. Beginning in February of 2013, the Company began developing a dry herbal vaporizer. The dry herbal vaporizer was in development and testing as of the end of June 30, 2014 and is expected to be available by early to mid 2015.
	Going Concern
	The Company has limited working capital, has incurred losses in each of the past two years, and has not yet received material revenues from sales of products or services. These factors create substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.
	The ability of RFMK to continue as a going concern is dependent on the Company generating cash from the sale of its common stock and/or obtaining debt financing and attaining future profitable operations. During the year ended December 31, 2014, the Company funded operations through the receipt of $100,000 in convertible notes payable, $550,000 in connection with proceeds received in connection with the sale of Series A2 Convertible Preferred stock and $50,000 in connection with the sale of Series C Convertible Preferred stock. As of December 31, 2014, the Company still have subscriptions receivable from sales of Series A2 Convertible Preferred stock and Series C Convertible Preferred stock of $566,000 and $4,950,000, respectively. Subsequent to year end, the Company has received $100,000 in proceeds related to Series A2 Convertible Preferred stock. Management’s plans include collecting on the remaining sales of Series A2 Convertible Preferred stock and Series C Convertible Preferred stock, selling its equity securities and obtaining debt financing to fund its capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.
	The financial statements have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that might result from the outcome of this uncertainty.
	Risks and Uncertainties
	The Company has a limited operating history and has not generated significant revenues from our planned principal operations.
	The Company’s business and operations are sensitive to general business and economic conditions in the U.S. and worldwide. These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the general condition of the U.S. and world economy. A host of factors beyond the Company’s control could cause fluctuations in these conditions, including the political environment and acts or threats of war or terrorism. Adverse developments in these general business and economic conditions, including through recession, downturn or otherwise, could have a material adverse effect on the Company’s financial condition and the results of its operations.
	The Company currently has minimal sales and limited marketing and/or distribution capabilities. The Company has limited experience in developing, training or managing a sales force and will incur substantial additional expenses if we decide to market any of our current and future products. Developing a marketing and sales force is also time consuming and could delay launch of our future products. In addition, the Company will compete with many companies that currently have extensive and well-funded marketing and sales operations. Our marketing and sales efforts may be unable to compete successfully against these companies. In addition, the Company has limited capital to devote sales and marketing.
	The Company’s industry is characterized by rapid changes in technology and customer demands. As a result, the Company’s products may quickly become obsolete and unmarketable. The Company’s future success will depend on its ability to adapt to technological advances, anticipate customer demands, develop new products and enhance our current products on a timely and cost-effective basis. Further, the Company’s products must remain competitive with those of other companies with substantially greater resources. The Company may experience technical or other difficulties that could delay or prevent the development, introduction or marketing of new products or enhanced versions of existing products. Also, the Company may not be able to adapt new or enhanced products to emerging industry standards, and the Company’s new products may not be favorably received. Nor may we have the capital resources to further the development of existing and/or new ones.
	The Company’s operations are subject to new innovations in product design and function. Significant technical changes can have an adverse effect on product lives. Design and development of new products are important elements to achieve and maintain profitability in the Company’s industry segment. The Company may be subject to federal, state and local environmental laws and regulations. The Company does not anticipate expenditures to comply with such laws and does not believe that regulations will have a material impact on the Company’s financial position, results of operations, or liquidity. The Company believes that its operations comply, in all material respects, with applicable federal, state, and local environmental laws and regulations

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies
	Basis of Presentation
	The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Cash and Cash Equivalents
	The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly- liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.
	Inventory
	Inventory consists of two finished products, the CANNAcig Vapor Inhaler and the Cumulus Vapor Inhaler, which are valued at the lower of cost or market valuation under the first-in, first-out method of costing. In addition, deposits on inventory consist of monies advanced to the contract manufacturer in connection with the production of our new dry herbal vaporizer which expected to be put into production in early 2015.
	Product obsolescence may be caused by changes in technology, discontinuance of a product line, replacement products in the marketplace or other competitive situations. The Company maintains a reserve on inventories that are considered to be slow moving or obsolete, to reduce the inventory to their net estimated realizable value. Once specific inventory is written-down, the write-down is permanent until the inventory is physically disposed of. During the year ended December 31, 2014, the Company recorded an obsolescence reserve of $89,563 due to lack of current sales and our an anticipated new product line to be issued in 2015.
	Property and Equipment
	Property and equipment are stated at cost. Major improvements and betterments are capitalized. Maintenance and repairs are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful life. At the time of retirement or other disposition of property and equipment, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is reflected in the statements of operations as other gain or loss, net.
	Revenue Recognition
	The Company generates revenue from the product sales of the CANNAcig Vapor Inhaler and the Cumulus Vapor Inhaler product sales of Bionic cigarettes revenue is recognized when the purchase is complete and shipment has occurred.
	Shipping and handling fees and costs incurred are included as an offset to general and administrative expenses. The amount of revenue received for shipping and handling is less than 5% of revenues for all periods presented.
	Sales tax collected from customers is not recorded as revenue. Sales tax collected is included in accounts payable until remitted to the taxing authorities.
	Research and Development
	All research and development costs, including licensing costs, are charged to expense as incurred. In accordance with this policy, all costs associated with the design, development and testing of the Company’s products have been expensed as incurred.
	Stock-Based Compensation
	The Company follows ASC 718-10, “Stock Compensation”, which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options. The Company granted stock awards, at market value, to its advisors for services rendered. Accordingly, stock-based compensation has been recorded to date.
	Income Taxes
	Income taxes are provided in accordance with ASC 740, “Income Taxes”, which requires an asset and liability approach for the financial accounting and reporting of income taxes. Current income tax expense (benefit) is the amount of income taxes expected to be payable (receivable) for the current year. A deferred tax asset and/or liability is computed for both the expected future impact of differences between the financial statement and tax bases of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. Deferred income tax expense is generally the net change during the year in the deferred income tax asset and liability. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be “more likely than not” realized in future tax returns. Tax rate changes and changes in tax law are reflected in income in the period such changes are enacted.
	Fair Value of Financial Instruments
	Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:
	Level 1. Observable inputs such as quoted prices in active markets;
	Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
	Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
	The Company did not have any level 1 or level 3 financial instruments at December 31, 2014 and 2013. As of December 31, 2014, the derivative liabilities were considered a level 2 item; see Note 3. As of December 31, 2013, the Company had no level 2 financial instruments.
	The carrying amounts reported in the accompanying financial statements for current assets and current liabilities approximate the fair value because of the immediate or short term maturities of the financial instruments.
	Earnings (Loss) per Share
	Basic earnings (loss) per share are computed by dividing the net income (loss) by the weighted-average number of shares of common stock and common stock equivalents (primarily outstanding shares of convertible debt, preferred stock, options and warrants). Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding stock options and warrants, using the treasury stock method. The calculation of fully diluted earnings (loss) per share assumes the dilutive effect of the exercise of outstanding convertible debt, preferred stock, options and warrants at either the beginning of the respective period presented or the date of issuance, whichever is later. As of December 31, 2014 and 2013, the Company’s dilutive securities consisted of convertible notes payable and Series A1, Series A2 and Series C preferred stock. If the holders of the convertible notes payable, Series A1 Preferred Stock, Series A2 Preferred Stock and Series C Preferred Stock all converted, the Company would be in excess of their authorized shares. The outstanding dilutive securities have been excluded from the calculation of diluted net loss per share because the effect would have been anti-dilutive for the years ended December 31, 2014 and 2013.

Convertible_Notes_Payable_and_

Convertible Notes Payable and Derivative Liabilities	12 Months Ended
	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Convertible Notes Payable and Derivative Liabilities	Note 3 – Convertible Notes Payable and Derivative Liabilities
	As of January 28, 2014, the Company had incurred amounts of $82,500 owed to Pyrenees Investments, LLC for service rendered. On January 28, 2014, the indebtedness was sold to Iconic Holdings, LLC, a third party. In connection with this sale, the Company issued a $82,500 convertible note to the third party. The convertible note incurs interest at 10% per annum and is due January 24, 2015. If a default is called by the lender after failure to repay principal or interest when due, among other default provisions including untimely filings with the SEC, a default interest rate of 20% per annum is triggered and retrospectively applied from the note’s inception date on the unpaid amount, and in addition the principal balance is increased by 150% of the face amount of the note deemed in default. At any time the note may be converted into shares of common stock, at the lower of $0.0006 or 50% discount off the lowest trading price for the Company’s common stock within the twenty (20) days preceding the conversion. The Company recorded a discount totaling $82,500 related to the beneficial conversion feature embedded in the note upon issuance. See below for discussion of derivative liabilities related to the conversion feature due to the absence of a conversion floor. In connection with this agreement, the Company reserved 250,000,000 shares of its common stock with the transfer agent. During the year ended December 31, 2014, the holder converted $50,000 into shares of common stock, see below for additional information.
	In February 2014 and October 2014, the Company borrowed $100,000 and $25,000, respectively, as evidenced by a convertible note issued to Iconic Holdings as part of a total note agreement of $165,000, including a $15,000 on issuance discount, which was entered into on January 28, 2014. The Company has yet to receive the remaining $25,000 in proceeds in which an additional $2,500 of an issuance discount will be recorded. The convertible note incurs interest at 10% per annum and is due January 28, 2015. If a default is called by the lender after failure to repay principal or interest when due, among other default provisions including untimely filings with the SEC, a default interest rate of 20% per annum is triggered and retrospectively applied from the note’s inception date on the unpaid amount, and in addition the principal balance is increased by 150% of the face amount of the note deemed in default. At any time the note may be converted into common stock, at the lower of $0.0006 or 50% discount off the lowest trading price for the Company’s common stock within the twenty (20) days preceding the conversion. The Company recorded a discount totaling $137,500, which included $12,500 for the on issuance discount, related to the beneficial conversion feature embedded in the note upon issuance. See below for discussion of derivative liabilities related to the conversion feature due to the absence of a conversion floor. In connection with this agreement, the Company reserved 250,000,000 shares of its common stock with the transfer agent. During the year ended December 31, 2014, the holder converted $55,000 into shares of common stock, see below for additional information.
	During the year ended December 31, 2014, the holder converted $105,000 of principal into 410,984,849 shares of common stock. In connection with these conversions, derivative liabilities of $170,332 were reclassed to additional paid-in capital. During the year ended December 31, 2014, the Company amortized $194,233 of the discount to interest expense. As of December 31, 2014, a discount of $25,767 remained which will be recognized during the year ended December 31, 2015.
	Derivative Liabilities
	The Company calculated the derivative liability using the Black-Scholes pricing model for each note upon inception and recorded the fair market value of the derivative liability as a discount to the note. When a derivative liability associated with a convertible note is in excess of the face value of the convertible note, the excess of fair value of derivative is charged to the statement of operations.
	During the year ended December 31, 2014, the Company issued convertible debt with principal and OID amounts totaling $220,000. At the inception of these notes, they were fully discounted due to value of the associated derivative liabilities. At December 31, 2014, the aggregate remaining discounts on convertible notes to be accreted over the life of each respective note using the straight line method are $25,767. For the year ended December 31, 2014, interest expense from accretion of the discount was $194,233.
	Aggregate derivative liabilities associated with remaining convertible notes were $177,323 as of December 31, 2014. Based on this revaluation at year end and the revaluation of derivative liabilities measured during the period immediately before extinguishment of associated convertible notes, the Company recognized a loss related to the day one value of the derivative liabilities of $1,045,882 and a loss (gain) in the change of fair value of derivative liability of ($915,727) during the year ended December 31, 2014.
	The following are the weighted average variable used in determining the fair market value of the Company’s derivative liabilities during the year ended December 31, 2014:
	Date	28-Jan-14			28-Feb-14			30-Sep-14			31-Dec-14
	Closing stock price of common stock	$	0.0017		$	0.0017		$	0.0005		$	0.0005
	Conversion price	$	0.0002		$	0.0006		$	0.0002		$	0.0002
	Expected life in years		1			1			0.33			0.08
	Risk free rate		0.11	%		0.11	%		0.03	%		0.03	%
	Expected annual volatility		294.7	%		301.7	%		309.9	%		248	%
	Dividend percentage		0	%		0	%		0	%		0	%

Subscriptions_Receivables

Subscriptions Receivables	12 Months Ended
	Dec. 31, 2014
Receivables [Abstract]
Subscriptions Receivables	Note 4 – Subscriptions Receivables
	As of December 31, 2014 and 2013, the Company held 11 and 29 notes receivable (the “Series A2 Notes”) from Ironridge Global IV, Ltd totaling $550,000 and $1,100,000, respectively, related to the sale of Series A2 Convertible Preferred Stock (see below for rights and preferences). The principal balance outstanding under the Series A2 Notes bears interest at the rate of 1.0% per annum. The entire unpaid principal balance, interest and any other charges due and payable under these Series A2 Notes will become due and payable 29 months from the date of issuance (September 21, 2012) and is recorded as a reduction to Stockholders’ Equity (Deficit) on the accompanying balance sheets. The Series A2 Notes shall be deemed not due and payable should the Company not have either 1) a registration statement on file and effective with the SEC covering the underlying common shares issuable as a result of the Preferred Shares, or 2) that the underlying common shares are eligible for trading under the then current Rule 144 as promulgated by the Securities of Act of 1933, as amended. The Company is also required to maintain adequate coverage of authorized shares, and must have the ability to issue common shares to the holder of the preferred shares in electronic format. Other customary events of default also apply. As of December 31, 2014 and 2013, approximately $550,000 and $1,100,000, respectively, of the Series A2 Notes balance remained unpaid. During the years ended December 31, 2014 and 2013, the Company received $550,000 and $350,000, respectively, in proceeds related to the payment of the Series A2 Notes and recorded interest income of $8,155 and $12,322, respectively. In addition, subscription receivables includes $16,000 in excess common stock in which was issued to the holders of Series A2 Notes which needs to be remitted by the holder.
	On March 27, 2014, the Company entered into an agreement with the same party discussed above for the issuance of 100 notes receivable (the “Series C Notes”) from one issuer totaling $5,000,000 related to the sale of Series C Convertible Preferred Stock (see below for rights and preferences). The principal balance outstanding under the Series C Notes bears interest at the rate of 1.0% per annum. The entire unpaid principal balance, interest and any other charges due and payable under these Series C Notes will become due and payable 82 weeks from the date of issuance and is recorded as a reduction to Stockholders’ Equity on the accompanying balance sheet. The Series C Notes deemed not due and payable should the Company not have either 1) a registration statement on file and effective with the SEC covering the underlying common shares issuable as a result of the preferred shares, or 2) that the underlying common shares are eligible for trading under the then current Rule 144 as promulgated by the Securities of Act of 1933, as amended. The Company is also required to maintain adequate coverage of authorized shares, and must have the ability to issue common shares to the holder of the preferred shares in electronic format. Other customary events of default also apply. As of December 31, 2014, $4,950,00 of the Series C Notes balance remained unpaid. During the year ended December 31, 2014, the Company received $50,000 in proceeds related to the payment on the Series C Notes. Additional, proceeds are dependent upon the Company maintaining sufficient authorized shares.

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Stockholders' Equity	Note 5 – Stockholders’ Equity
	Preferred Stock
	Series A1 Preferred Stock
	On September 6, 2011, the Company filed a Certificate of Designation of Series A1 Convertible Preferred Stock (“Series A1”) with the Secretary of State of Nevada. Pursuant to the Series A1 Certificate of Designation, the Company designated 25,000,000 shares of its blank check preferred stock as Series A1 Preferred Stock. The Series A1 Preferred Stock ranks senior to the common stock (the “Junior Stock”). The Series A1 Preferred Stock can be converted at anytime into 30 common shares per one preferred share. In the event of a liquidation, the Series A1 Preferred Stock will be entitled to a liquidation at the same as common stock. The Series A1 Preferred Stock has no voting rights.
	Series A2 Preferred Stock
	On October 5, 2012, the Company filed a Certificate of Designation of Series A2 Convertible Preferred Stock (“Series A2”) with the Secretary of State of Nevada. Pursuant to the Series A2 Certificate of Designation, the Company designated 300 shares of its blank check preferred stock as Series A2 . The Series A2 ranks senior to the common stock and any subsequently created series of preferred stock that does not expressly rank pari passu with or senior to the Series A2 (the “Junior Stock”). The Series A2 can be converted at anytime and has a fixed conversion price of $0.00225 per common share. The Series A2 is entitled to minimum six years worth of dividends accruing at a rate of 8.5% per annum potentially increasing to 18% per annum under certain circumstances such as a significant decrease in the price of the Company’s common stock. Dividends are payable in cash or in shares of common stock valued at 85.0% of the closing market price of the Company’s common stock for any trading day following the issuance date of the Series A2. In the event of a liquidation, the Series A2 will be entitled to a payment of the Stated Value of $10,000 per share plus any accrued but unpaid dividends prior to any payments being made in respect of the Junior Stock. The holders of Series A2 do not have voting rights, except for shares in which have already been converted into shares of common stock.
	On January 8, 2014, the holder converted 10 Series A2 shares into 44,444,444 shares of common stock. In addition, under the terms of the Series A2 the holder was entitled to immediate payment of dividends on the $100,000 stated value of the Series A2 at an annual dividend rate of 18% rate, which is an increase over the stated 8.5% due to adjustments related to the decrease in the fair market value of the Company’s common stock, for a period of six years resulting in dividends payable of $108,000. The holder elected to convert the dividends to common stock based upon 85% of the closing market price as disclosed above resulting in a conversion price of $0.00017 with 635,294,118 common shares being issued. On the date of conversion, the fair market value of the dividend shares issued was $1,334,118 based upon the closing market price of the Company’s common stock. Thus, the Company recorded additional expense of $1,334,118 in connection with the dividend shares issued.
	On February 11, 2014, the holder converted 15 Series A2 shares into 66,666,666 shares of common stock. In addition, under the terms of the Series A2 the holder was entitled to immediate payment of dividends on the $150,000 stated value of the Series A2 at an annual dividend rate of 18% rate, which is an increase over the stated 8.5% due to adjustments related to the decrease in the fair market value of the Company’s common stock, for a period of six years resulting in dividends payable of $162,000. The holder elected to convert the dividends to common stock based upon 85% of the closing market price as disclosed above resulting in a conversion price of $0.00017 with 952,941,176 common shares to be issued. On the date of conversion, the fair market value of the dividend shares issued was $3,144,706 based upon the closing market price of the Company’s common stock. Thus, the Company recorded additional expense of $3,144,706 in connection with the dividend shares issued. During the year ended December 31, 2014, the Company has issued 756,000,000 shares of common stock relieving the “Shares to Be Issued” account by $2,341,467. As of December 31, 2014, the Company has recorded within stockholders’ equity “Shares to Be Issued” of $869,906 as 263,607,842 common shares have not been delivered due to the 9.99% ownership limitation placed on the shareholders. During the years ended December 31, 2014 and 2013, the Company accrued dividends related to the Series A2 shares of $104,543 and $126,140, respectively. As of December 31, 2014 and 2013, accrued Series A2 dividends recorded within accounts payable and accrued liabilities on the accompanying balance sheet were $230,683 and $126,140, respectively.
	Series B Preferred Stock
	On February 28, 2013, the Company filed a Certificate of Designation of Series B Convertible Preferred Stock (“Series B”) with the Secretary of State of Nevada. Pursuant to the Series B Certificate of Designation, the Company designated 16,000,000 shares of its blank check preferred stock as Series B. The Series B ranks senior to the common stock and any subsequently created series of preferred stock that does not expressly rank pari passu with or senior to the Series B (the “Junior Stock”). The Series B cannot be converted into any other securities and does not receive dividends. Each share of Series B shall have voting rights equal to that of 2,000 shares of common stock. In the event of a liquidation, the Series B will be entitled to net assets on a pro rata basis.
	On March 1, 2013, the Company issued its Chief Executive Officer 16,000,000 shares of Series B Preferred Stock. The only rights the holder under the Series B has relates to voting control of the Company, which prior to the issuance the Chief Executive Officer, was the only officer and Board of Director member and already could make significant decisions, however, the Chief Executive Officer lacked voting control due to limited equity holdings in the Company. The issuance transferred voting control of the Company to the Chief Executive Officer. The Company determine the fair market value of the Series B to be $2,091,885 based upon the 61.65% of the Company’s market capitalization on the date of the issuance. The percentage used in the calculation reflects a fully diluted basis at the time of the agreement.
	Series C Preferred Stock
	On March 27, 2014, the Company filed a Certificate of Designation of Series C Convertible Preferred Stock (“Series C”) with the Secretary of State of Nevada. Pursuant to the Series C Certificate of Designation, the Company designated 5,000 shares of its blank check preferred stock as Series C. The Series C ranks senior to the common stock and any subsequently created series of preferred stock that does not expressly rank pari passu with or senior to the Series C (the “Junior Stock”) and pari passu in rights to dividends and liquidation to the Series A2 and junior to all existing and future indebtedness of the Company. The Series C can be converted at anytime and has a fixed conversion price of $0.01 per common share. The Series C is entitled to minimum six years worth of dividends accruing at a rate of 8.5% per annum potentially increasing to 18% per annum under certain circumstances such as a significant decrease in the price of the Company’s common stock. Dividends are payable in cash or in shares of common stock valued at 85.0% of the closing market price of the Company’s common stock for any trading day following the issuance date of the Series C. In the event of a liquidation, the Series C will be entitled to a payment of the Stated Value of $10,000 per share plus any accrued but unpaid dividends prior to any payments being made in respect of the Junior Stock. The holders of Series C do not have voting rights, except for shares in which have already been converted into shares of common stock. During the year ended December 31, 2014, the Company issued 5,000 shares of Series C for a subscription receivable of $5.0 Million; see Note 4 for additional information. During the year ended December 31, 2014, the Company accrued dividends related to the Series C shares of $320,430 of which were also included within accounts payable and accrued liabilities on the accompanying financial statements.
	Common Stock
	On November 3, 2014, the State of Nevada approved to increase the Company’s authorized shares from 5 billion to 20 billion.
	During the year ended December 31, 2014, the Company issued 1,754,386 shares of common stock valued at $4,737 based upon the closing market price of the Company’s common stock on the date of the agreement to a third party for the rights to future royalties related to Global Specialty Products, Inc.’s MicroRoasters brand.
	In addition, the Company amortized $60,000 of deferred compensation related to common stock granted during the year ended December 31, 2013 which is being expensed over the service period. As of December 31, 2014, the Company had $0 of amortization remaining.
	Additionally, during the year ended December 31, 2014, the Company issued 50,000,000 shares of common stock valued at $135,000 based upon the closing market price of the Company’s common stock on the on the date of the agreement to a third party for sales and marketing services. The fair market value of the common stock issued was recorded as prepaid expenses and is being amortized over the contract period of one year. During the year ended December 31, 2014, the Company amortized $112,500 to sales and marketing on the accompanying statement of operations. As of December 31, 2014, the remaining prepaid is $22,500. In addition, as of the date of this filing the common stock has not been issued and thus the value of $135,000 is recorded within stock to be issued on the accompanying balance sheet.
	On January 27, 2014, the Company entered into a settlement with the prior management whereby prior management agreed to return 60,000,000 shares of the Company’s common stock previously issued to them for services rendered. In return, the Company has agreed to release prior management from any claims related to all costs deemed of a non-business nature. The Company accounted for the shares at their par value of $60,000 reducing common stock by that amount with the reclass to additional paid in capital. Upon return, the common stock was cancelled by the transfer agent and reflected in our calculation of weighted average shares for the year ended December 31, 2014 as of the date of the agreement.
	During the years ended December 31, 2014 and 2013, the Company recorded compensation expense of $170,000 and $318,333, respectively related to common stock issued under the Chief Executive Officer’s employment agreement. During the year ended December 31, 2014, the Company issued 100,000,000 shares of common stock due under the employment agreement. The shares were valued on date of the agreement being amortized over the term. Expected future compensation to be recorded during the years ended December 31; $170,000 for 2015 and $56,667 for 2016.
	During the year ended December 31, 2014, the Company issued 150,000,000 shares of common stock in connection with the conversion of 5,000 shares of Series A1 Preferred Stock with a carrying value of $5,000 held by the former Chief Executive Officer.
	During the year ended December 31, 2013, the Company issued 780,000,000 shares of common stock. Of this amount 43,089,214 shares were issued for services; 90,000,000 shares of stock were issued from the conversion of 3,000,000 shares of preferred stock, and the balance of 646,910,786 shares were issued for a settlement of debt valued at $561,518 of which $349,355 was recorded as a loss on shares issued.
	Ironridge Global IV, Ltd.
	On September 19, 2012, the Supreme Court of the State of California for the County of Los Angeles Central District (the “Court”), entered an order (the “Order”) approving, among other things, the fairness of the terms and conditions of an exchange pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended (the “Securities Act”), in accordance with a stipulation of settlement (the “Settlement Agreement”) between the Company, and Ironridge Global IV, Ltd. (“Ironridge”), in the matter entitled Ironridge Global IV, Ltd. v. Rapid Fire Marketing, Inc., Case No. BC 490059 (the “Action”). Ironridge commenced the Action against the Company to recover an aggregate of $643,133 of past-due accounts payable of the Company, plus fees and costs (the “Claim”). The Order provides for the full and final settlement of the Claim and the Action. The Settlement Agreement became effective and binding upon the Company and Ironridge upon execution of the Order by the Court on September 19, 2012. The amounts due to Ironridge had previously been recorded within accounts payable but were reclassed to common stock to be issued within stockholders’ equity upon settlement as the obligation was to be settled in shares of common stock. Upon issuance of common stock, the Company determines the fair market value of the common shares issued based upon the closing market price of the Company’s common stock. The fair value of the common stock issued in excess of the reduction of the liability is recorded as a loss on common shares issued. The Company periodically issued common shares to Ironridge (up to their ownership percentage so as not to exceed 9.99%) until all amounts were paid in full.
	The issuance of common stock to Ironridge pursuant to the terms of the Settlement Agreement approved by the Order is exempt from the registration requirements of the Securities Act pursuant to Section 3(a)(10) thereof, as an issuance of securities in exchange for bona fide outstanding claims, where the terms and conditions of such issuance are approved by a court after a hearing upon the fairness of such terms and conditions at which all persons to whom it is proposed to issue securities in such exchange shall have the right to appear. See Note 4 for discussion of additional transactions with Ironridge.
	In connection with the Ironridge matter described above, as well as other negotiated settlements, the Company recognized a loss on the share issuance in the amount of $424,741 during the year ended December 31, 2013 in connection with the issuance of 974,399,306 shares of common stock. As of December 31, 2013, no additional common shares were issuable as the settlement amount had been fully satisfied.
	Equity Line of Credit
	On February 28, 2014, the Company, entered into an Equity Line of Credit (the “Equity Line of Credit”) with Iconic Holdings, LLC (“Iconic”). Pursuant to the Equity Line of Credit, Iconic committed to purchase up to $2,000,000 of the Company’s common stock over twenty-four months from the first day following the effectiveness of a registration statement, subject to certain conditions.
	As soon as the Company has an effective registration statement in place, the Company may draw on the facility from time to time, as and when it determines appropriate in accordance with the terms and conditions of the related Equity Line of Credit. The Company has not yet filed a registration statement registering the shares and therefore, it has not yet sold any shares under the Equity Line of Credit. The purchase price will be 85% of the lowest trading price of the Company’s common stock during the five (5) consecutive trading day period beginning on the trading day immediately following the date of delivery of the applicable put notice. The maximum amount that the Company is entitled to put in on any one notice shall be any amount up to the greater of 1) the average of the trading dollar volume of the Company’s common stock during the ten (10) trading days preceding the request or 2) $100,000. Iconic is not obligated to purchase shares if its total number of shares beneficially held at that time would exceed 4.99% of the number of shares of the Company’s outstanding common stock as determined in accordance with Rule 13d-1 of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the facility unless there is an effective registration statement to cover the resale of the shares, which it does not currently have in place.
	Pursuant to the terms of a Registration Rights Agreement between the Company and Iconic, the Company is obligated to file a registration statement with the SEC to register the resale by Iconic of shares of the common stock underlying the Investment Agreement and it has not yet done so.
	In addition, under the terms of the Equity Line of Credit the Company was required to issue Iconic 10% of the total commitment amount in restricted common stock as a commitment fee. To date the Company issued 82,217,378 shares of common stock valued at $209,810 based upon the closing market price of the Company’s common stock on the date of the agreement. The Company initially recorded the value of such common stock as a deferred offering cost and expected to offset the amount against future proceeds received in connection with Equity Line of Credit. As of December 31, 2014, no proceeds have been received under the Equity Line of Credit and the Company determined that future proceeds were not probable. Thus, the amount was written off as general and administrative expense at December 31, 2014.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 – Related Party Transactions
	On March 28, 2013, the Company executed a 3% convertible note with a shareholder for $9,500 due within one year. The note is convertible into the Company’s common stock at a rate of $0.001 per share subject to various adjustments due to stock splits, change in control, etc. As of December 31, 2014, the note was in default, however, a demand for payment has not been received.
	On November 29, 2012, the Company executed a 3% convertible note with a shareholder for $14,000 due within one year. The note is convertible into the Company’s common stock at the lesser of $0.001 per share (subject to various adjustments due to stock splits, change in control, etc) or a 20% discount to the current bid price on the date of conversion. As of December 31, 2014, the note was in default, however, a demand for payment has not been received.
	As of December 31, 2014, amounts due to our Chief Executive Officer for salary payable recorded within Accounts Payable on the accompanying balance sheet were $30,430.
	See Note 5 for Series B and common stock issued to the Chief Executive Officer.

Commitments

Commitments	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 7 – Commitments
	The Company neither owns nor leases any real or personal property. The Company’s Chief Executive Officer provides office services without charge. There is no obligation for the officer to continue this arrangement. Such costs are immaterial to the financial statements and accordingly are not reflected herein. The officers and directors are involved in other business activities and most likely will become involved in other business activities in the future. In addition, the Company uses a third party fulfiller to house and procure their sales based upon a monthly fee schedule.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	Note 8 – Income Taxes
	For the years ended December 31, 2014 and 2013, the Company has incurred net losses before and, therefore, has no tax liability. The net deferred tax asset generated by the loss carry-forward has been fully reserved. The cumulative net operating loss carry-forward from is approximately $15,570,000 and $14,158,000 at December 31, 2014 and 2013, respectively, and will expire beginning in the year 2028. The primary difference between the Company’s statutory and effective tax rate relates to permanent differences for items in which are not deductible for tax purposes.
	The provision for Federal income tax consists of the following for the years ended December 31, 2014 and 2013:
		31-Dec-14			31-Dec-13
	Federal income tax benefit attributable to:
	Current operations	$	480,009		$	419,050
	Less: valuation allowance		(480,009	)		(419,050	)
	Net provision of income taxes	$	-		$	-
	The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of December 31, 2014 and 2013:
		31-Dec-14			31-Dec-13
	Deferred tax asset attributable to:
	Net operating loss carryforward	$	5,293,630		$	4,813,621
	Less: valuation allowance		(5,293,630	)		(4,813,621	)
	Net deferred tax asset	$	-		$	-
	Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $15,570,000 for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years.
	The Company has identified the United States Federal tax returns as its “major” tax jurisdiction. The United States Federal return years 2010 through 2014 are still subject to tax examination by the United States Internal Revenue Service; however, we do not currently have any ongoing tax examinations. The Company is subject to examination by the California Franchise Tax Board for the years ended 2010 through 2014 and currently does not have any ongoing tax examinations.

Restatement

Restatement	12 Months Ended
	Dec. 31, 2014
Restatement
Restatement	Note 9 – Restatement
	The Company has amended the year ended December 31, 2013 for the following transactions:
	The Series A2 is entitled to dividends accruing at a rate of 8.5%. During the year ended December 31, 2013, the Company did not accrue the dividends. Thus, the Company recorded an adjustment of $126,140 to accounts payable and accrued liabilities with interest expense as the offset during the year ended December 31, 2013 to correct this error.
	On March 1, 2013, the Company issued its Chief Executive Officer 16,000,000 shares of Series B Preferred Stock. The Company determine the fair market value of the Series B to be $2,091,885, see Note 5 for additional information. The transactions wasn’t initially accounted for during the year ended December 31, 2013.
	The Company incorrectly accounted for shares to be issued under the Chief Executive Officer’s employment agreement. To correct, the Company recorded compensation expense of $318,333 during the year ended December 31, 2013. See Note 5.
	Balance Sheet:
		Originally Filed						As Restated
		Year Ended						Year Ended
		31-Dec-13			Adjustments			31-Dec-13
	Accounts payable and accrued liabilities	$	179,540		$	126,140		$	305,680
	Total liabilities	$	203,040		$	126,140		$	329,180
	Preferred stock	$	7,790		$	16,000		$	23,790
	Additional paid in capital		12,597,276			2,394,218			14,991,494
	Accumulated deficit		(14,157,710	)		(2,536,358	)		(16,694,068	)
	Total stockholders’ equity (deficit)	$	50,869			(126,140	)	$	(75,271	)
	Statement of Operations:
		Originally Filed						As Restated
		Year Ended						Year Ended
		31-Dec-13			Adjustments			31-Dec-13
	Stock for services	$	80,000		$	2,410,218		$	2,490,218
	Interest expense		674			126,140			126,814
	Net loss	$	(1,232,501	)	$	(2,536,358	)	$	(3,768,859	)
	Basic and diluted loss per share	$	(0.00	)	$	-		$	(0.00	)
	Weighted average shares outstanding		2,169,422,459			-			2,169,422,459
	Statement of Cash Flows:
		Originally Filed						As Restated
		Year Ended						Year Ended
		31-Dec-13			Adjustments			31-Dec-13
	Net loss	$	(1,232,501	)		(2,536,358	)	$	(3,768,859	)
	Stock for services		80,000			2,410,218			2,490,218
	Accounts payable and accrued liabilities		73,830			126,140			199,970
	Net cash used in operating activities	$	(358,871	)	$	-		$	(358,871	)

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	Note 10 – Subsequent Events
	Subsequent to year end, the Company received $100,000 in proceeds related to Series A2 Convertible Preferred stock.
	Subsequent to year end, the Company issued 562,941,177 shares of common stock in connection with conversions of Series A2. Of these 66,666,667 shares of common stock was owed under a February 2014 conversion.
	Subsequent to year end, the Company issued 251,166,667 shares of common stock in connection with conversions of Series A1.
	Subsequent to year end, the Company issued 831,755,454 shares of common stock in connection with conversions of convertible notes payable.
	In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2014 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements other than the events described above.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
	The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars.
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents
	The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly- liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.
Inventory	Inventory
	Inventory consists of two finished products, the CANNAcig Vapor Inhaler and the Cumulus Vapor Inhaler, which are valued at the lower of cost or market valuation under the first-in, first-out method of costing. In addition, deposits on inventory consist of monies advanced to the contract manufacturer in connection with the production of our new dry herbal vaporizer which expected to be put into production in early 2015.
	Product obsolescence may be caused by changes in technology, discontinuance of a product line, replacement products in the marketplace or other competitive situations. The Company maintains a reserve on inventories that are considered to be slow moving or obsolete, to reduce the inventory to their net estimated realizable value. Once specific inventory is written-down, the write-down is permanent until the inventory is physically disposed of. During the year ended December 31, 2014, the Company recorded an obsolescence reserve of $89,563 due to lack of current sales and our an anticipated new product line to be issued in 2015.
Property and Equipment	Property and Equipment
	Property and equipment are stated at cost. Major improvements and betterments are capitalized. Maintenance and repairs are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful life. At the time of retirement or other disposition of property and equipment, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is reflected in the statements of operations as other gain or loss, net.
Revenue Recognition	Revenue Recognition
	The Company generates revenue from the product sales of the CANNAcig Vapor Inhaler and the Cumulus Vapor Inhaler product sales of Bionic cigarettes revenue is recognized when the purchase is complete and shipment has occurred.
	Shipping and handling fees and costs incurred are included as an offset to general and administrative expenses. The amount of revenue received for shipping and handling is less than 5% of revenues for all periods presented.
	Sales tax collected from customers is not recorded as revenue. Sales tax collected is included in accounts payable until remitted to the taxing authorities.
Research and Development	Research and Development
	All research and development costs, including licensing costs, are charged to expense as incurred. In accordance with this policy, all costs associated with the design, development and testing of the Company’s products have been expensed as incurred.
Stock-Based Compensation	Stock-Based Compensation
	The Company follows ASC 718-10, “Stock Compensation”, which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options. The Company granted stock awards, at market value, to its advisors for services rendered. Accordingly, stock-based compensation has been recorded to date.
Income Taxes	Income Taxes
	Income taxes are provided in accordance with ASC 740, “Income Taxes”, which requires an asset and liability approach for the financial accounting and reporting of income taxes. Current income tax expense (benefit) is the amount of income taxes expected to be payable (receivable) for the current year. A deferred tax asset and/or liability is computed for both the expected future impact of differences between the financial statement and tax bases of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. Deferred income tax expense is generally the net change during the year in the deferred income tax asset and liability. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be “more likely than not” realized in future tax returns. Tax rate changes and changes in tax law are reflected in income in the period such changes are enacted.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:
	Level 1. Observable inputs such as quoted prices in active markets;
	Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
	Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
	The Company did not have any level 1 or level 3 financial instruments at December 31, 2014 and 2013. As of December 31, 2014, the derivative liabilities were considered a level 2 item; see Note 3. As of December 31, 2013, the Company had no level 2 financial instruments.
	The carrying amounts reported in the accompanying financial statements for current assets and current liabilities approximate the fair value because of the immediate or short term maturities of the financial instruments.
Earnings (loss) Per Share	Earnings (Loss) per Share
	Basic earnings (loss) per share are computed by dividing the net income (loss) by the weighted-average number of shares of common stock and common stock equivalents (primarily outstanding shares of convertible debt, preferred stock, options and warrants). Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding stock options and warrants, using the treasury stock method. The calculation of fully diluted earnings (loss) per share assumes the dilutive effect of the exercise of outstanding convertible debt, preferred stock, options and warrants at either the beginning of the respective period presented or the date of issuance, whichever is later. As of December 31, 2014 and 2013, the Company’s dilutive securities consisted of convertible notes payable and Series A1, Series A2 and Series C preferred stock. If the holders of the convertible notes payable, Series A1 Preferred Stock, Series A2 Preferred Stock and Series C Preferred Stock all converted, the Company would be in excess of their authorized shares. The outstanding dilutive securities have been excluded from the calculation of diluted net loss per share because the effect would have been anti-dilutive for the years ended December 31, 2014 and 2013.

Convertible_Notes_Payable_and_1

Convertible Notes Payable and Derivative Liabilities (Tables)	12 Months Ended
	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Convertible Notes Payable and Derivative Liabilities	The following are the weighted average variable used in determining the fair market value of the Company’s derivative liabilities during the year ended December 31, 2014:
	Date	28-Jan-14			28-Feb-14			30-Sep-14			31-Dec-14
	Closing stock price of common stock	$	0.0017		$	0.0017		$	0.0005		$	0.0005
	Conversion price	$	0.0002		$	0.0006		$	0.0002		$	0.0002
	Expected life in years		1			1			0.33			0.08
	Risk free rate		0.11	%		0.11	%		0.03	%		0.03	%
	Expected annual volatility		294.7	%		301.7	%		309.9	%		248	%
	Dividend percentage		0	%		0	%		0	%		0	%

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Provision for Federal Income Tax	The provision for Federal income tax consists of the following for the years ended December 31, 2014 and 2013:
		31-Dec-14			31-Dec-13
	Federal income tax benefit attributable to:
	Current operations	$	480,009		$	419,050
	Less: valuation allowance		(480,009	)		(419,050	)
	Net provision of income taxes	$	-		$	-
Schedule of Deferred Tax Asset	The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of December 31, 2014 and 2013:
		31-Dec-14			31-Dec-13
	Deferred tax asset attributable to:
	Net operating loss carryforward	$	5,293,630		$	4,813,621
	Less: valuation allowance		(5,293,630	)		(4,813,621	)
	Net deferred tax asset	$	-		$	-

Restatement_Tables

Restatement (Tables)	12 Months Ended
	Dec. 31, 2014
Restatement Tables
Schedule of Financial Restatements	Balance Sheet:
		Originally Filed						As Restated
		Year Ended						Year Ended
		31-Dec-13			Adjustments			31-Dec-13
	Accounts payable and accrued liabilities	$	179,540		$	126,140		$	305,680
	Total liabilities	$	203,040		$	126,140		$	329,180
	Preferred stock	$	7,790		$	16,000		$	23,790
	Additional paid in capital		12,597,276			2,394,218			14,991,494
	Accumulated deficit		(14,157,710	)		(2,536,358	)		(16,694,068	)
	Total stockholders’ equity (deficit)	$	50,869			(126,140	)	$	(75,271	)
	Statement of Operations:
		Originally Filed						As Restated
		Year Ended						Year Ended
		31-Dec-13			Adjustments			31-Dec-13
	Stock for services	$	80,000		$	2,410,218		$	2,490,218
	Interest expense		674			126,140			126,814
	Net loss	$	(1,232,501	)	$	(2,536,358	)	$	(3,768,859	)
	Basic and diluted loss per share	$	(0.00	)	$	-		$	(0.00	)
	Weighted average shares outstanding		2,169,422,459			-			2,169,422,459
	Statement of Cash Flows:
		Originally Filed						As Restated
		Year Ended						Year Ended
		31-Dec-13			Adjustments			31-Dec-13
	Net loss	$	(1,232,501	)		(2,536,358	)	$	(3,768,859	)
	Stock for services		80,000			2,410,218			2,490,218
	Accounts payable and accrued liabilities		73,830			126,140			199,970
	Net cash used in operating activities	$	(358,871	)	$	-		$	(358,871	)

Organization_and_Description_o1

Organization and Description of Business (Details Narrative) (USD $)	12 Months Ended	0 Months Ended
	Dec. 31, 2014	Mar. 27, 2014	Dec. 31, 2013
Convertible notes payable	$100,000
Subscription receivable from sales	5,516,000		1,116,000
Series A2 Preferred Stock [Member]
Proceeds from sale convertible preferred stock	550,000
Subscription receivable from sales	4,950,000
Proceeds from convertible preferred stock	100,000
Series C Preferred Stock [Member]
Subscription receivable from sales	566,000
Series C Preferred Stock [Member]
Proceeds from sale convertible preferred stock	50,000
Proceeds from convertible preferred stock		$5,000,000

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Inventory obsolence reserve	$89,563
Percentage of revenue	5.00%

Convertible_Notes_Payable_and_2

Convertible Notes Payable and Derivative Liabilities (Details Narrative) (USD $)	12 Months Ended		1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Nov. 29, 2012	Feb. 28, 2014	Jan. 28, 2014	Jan. 31, 2014	Mar. 28, 2013	Oct. 31, 2014
Derivative [Line Items]
Conversion of common stock	$50,000
Debt Instrument, Unamortized Discount	25,767	0
Interest expense	636,789	126,814
Amortization of Debt Discount (Premium)	-194,233
Derivative Liability, Current	177,323
Derivative, Gain (Loss) on Derivative, Net, Total	-130,155
Accretion of Discount	10,000
Debt Conversion, Converted Instrument, Amount	105,000
Common Stock [Member]
Derivative [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	263,607,842
Stock Issued During Period, Shares, Conversion of Convertible Securities	410,984,849
Warrant [Member]
Derivative [Line Items]
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt	170,332
February 2014 and October 2014 [Member]
Derivative [Line Items]
Conversion of common stock	55,000
Convertible Notes Payable [Member]
Derivative [Line Items]
Debt Instrument, Face Amount			14,000				9,500
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger			20.00%
Debt Instrument, Unamortized Discount	25,767
Interest expense	194,233
Derivative Liability	220,000
Amortization of Debt Discount (Premium)	194,233
Gains (Losses) on Extinguishment of Debt, Total	1,045,882
Derivative, Gain (Loss) on Derivative, Net, Total	915,727
Pyrenees Investments, LLC [Member]
Derivative [Line Items]
Due to Related Parties, Current					82,500
Iconic Holdings, LLC [Member] | Convertible Notes Payable [Member]
Derivative [Line Items]
Due to Related Parties, Current				100,000				25,000
Debt Instrument, Face Amount				165,000	82,500
Debt Instrument, Interest Rate, Stated Percentage				10.00%	10.00%
Debt Default Percentage Of Interest				20.00%	20.00%
Debt Instrument, Interest Rate, Increase (Decrease)				150.00%		150.00%
Debt Instrument, Maturity Date				28-Jan-15		24-Jan-15
Debt Instrument, Convertible, Stock Price Trigger				$0.00		$0.00
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger				50.00%		50.00%
Debt Instrument, Convertible, Beneficial Conversion Feature						82,500
Common Stock, Capital Shares Reserved for Future Issuance				250,000,000		250,000,000
Debt Instrument, Unamortized Discount	2,500			137,500	15,000
Proceeds from Related Party Debt				25,000
Debt Instrument, Convertible, Threshold Trading Days				20		20
Accretion of Discount				$12,500

Convertible_Notes_Payable_and_3

Convertible Notes Payable and Derivative Liabilities - Schedule of Convertible Notes Payable and Derivative Liabilities (Details) (Derivative Financial Instruments, Liabilities [Member], USD $)	1 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Feb. 28, 2014	Jan. 28, 2014
Derivative Financial Instruments, Liabilities [Member]
Derivative [Line Items]
Closing stock price of common stock	$0.00	$0.00	$0.00	$0.00
Conversion price	$0.00	$0.00	$0.00	$0.00
Expected life in years	29 days	3 months 29 days	1 year	1 year
Risk free rate	0.03%	0.03%	0.11%	0.11%
Expected annual volatility	248.00%	309.90%	301.70%	294.70%
Dividend percentage	0.00%	0.00%	0.00%	0.00%

Subscriptions_Receivables_Deta

Subscriptions Receivables (Details Narrative) (USD $)	12 Months Ended		0 Months Ended
	Dec. 31, 2013	Dec. 31, 2014	Mar. 27, 2014
Subscriptions Receivables [Line Items]
Stock issued during period, value, new issues	$440,741
Series A2 Convertible Preferred stock [Member]
Subscriptions Receivables [Line Items]
Proceeds from issuance of convertible preferred stock	1,100,000	550,000
Series C Preferred Stock [Member]
Subscriptions Receivables [Line Items]
Proceeds from issuance of convertible preferred stock			5,000,000
Series A2 Notes [Member]
Subscriptions Receivables [Line Items]
Number of notes receivable	29	11
Notes receivable, interest rate		1.00%
Notes receivable, related parties	1,100,000	550,000
Proceeds from collection of notes receivable	350,000	550,000
Interest income	12,322	8,155
Series C Notes [Member]
Subscriptions Receivables [Line Items]
Number of notes receivable			100
Notes receivable, interest rate			1.00%
Notes receivable, related parties		495,000
Proceeds from related party		$50,000

Stockholders_Equity_Details_Na

Stockholders' Equity (Details Narrative) (USD $)	12 Months Ended		0 Months Ended					1 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Sep. 19, 2012	Feb. 11, 2014	Jan. 27, 2014	Jan. 08, 2014	Oct. 05, 2012	Feb. 28, 2014	Feb. 28, 2013	Mar. 02, 2013	Mar. 27, 2014	Sep. 06, 2011	Nov. 03, 2014	Mar. 01, 2013
Class of Stock [Line Items]
Preferred stock, shares authorized		90,000,000
Common stock shares authorized	20,000,000,000	20,000,000,000
Conversion of stock, amount converted	$5,000	$3,000
Preferred stock, value, issued		23,790
Increase in subscription receivable	5,000,000
Compensation expenses		318,333
Stock issued during period, value, new issues		440,741
Common stock, shares, issued	4,609,208,217	2,789,513,042
Deferred sales inducements, amortization expense	112,500
Prepaid expense, current	22,500
Stock issued	135,000
Debt conversion, original debt, amount	82,500
Gain (loss) on sale of securities, net, total	-4,478,824	-424,741
December 31, 2015 [Member]
Class of Stock [Line Items]
Compensation expenses	170,000
December 31, 2016 [Member]
Class of Stock [Line Items]
Compensation expenses	56,667
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Accrued dividends	320,430
Ironridge Global IV, Ltd [Member]
Class of Stock [Line Items]
Loss contingency, damages sought, value			643,133
Convertible Debt [Member]
Class of Stock [Line Items]
Stock issued during period shares settlement of debt		646,910,786
Debt conversion, original debt, amount		561,518
Common Stock [Member]
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion	150,000,000					635,294,118		952,941,176				30
Conversion of stock, shares issued		90,000,000		66,666,666
Common stock, capital shares reserved for future issuance	263,607,842
Stock issued during period, shares, new issues	50,000,000	974,399,306
Amortization of other deferred charges	0	60,000
Share-based compensation arrangement by share-based payment award, options, forfeitures in period					60,000,000
Stock issued during period, value, share-based compensation, forfeited	60,000
Stock issued during period, value, new issues	135,000	974,399
Percentage of ownership	9.99%
Loss on share issuances		424,741
Stock issued during period, shares, issued for employment agreement	100,000,000	974,399,306
Gain (loss) on sale of securities, net, total	349,355
Common Stock [Member] | Minimum [Member]
Class of Stock [Line Items]
Common stock shares authorized													5,000,000,000
Common Stock [Member] | Maximum [Member]
Class of Stock [Line Items]
Common stock shares authorized													20,000,000,000
Common Stock [Member] | Global Specialty Products Inc [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues	1,754,386
Stock issued during period, value, new issues	4,737
Preferred Stock [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues		780,000,000
Stock issued during period, shares, issued for employment agreement		43,089,214
Conversion of stock, shares converted		3,000,000
Series A1 Convertible Preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	25,000,000	25,000,000										25,000,000
Accrued dividends	104,543
Preferred stock, shares issued	2,790,000	7,790,000
Preferred stock, value, issued	2,790	7,790
Series A2 Convertible Preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	300	300					300
Conversion of stock, shares issued		3,000,000				44,444,444
Convertible preferred stock conversion price						$0.00	$0.00	$0.00
Preferred stock, dividend rate, percentage						8.50%	8.50%	8.50%
Preferred stock dividend rate percentage increase						18.00%	18.00%	18.00%
Preferred stock dividend paid in stock percentage						85.00%	85.00%	85.00%
Preferred stock, liquidation preference, value							10,000
Payment of dividends						100,000
Dividends, preferred stock, total	100,000							150,000
Dividends payable, current				162,000
Conversion of stock, amount converted						1,334,118		3,144,706
Convertible preferred stock, shares reserved for future issuance	869,906
Preferred stock conversion percentage								9.99%
Accrued dividends		126,140
Accounts payable and accrued liabilities	230,683	126,140
Preferred stock, shares issued	125	150
Preferred stock, value, issued
Dividends, preferred stock, stock						1,334,118
Iconic Holdings, LLC [Member] | Line of Credit [Member]
Class of Stock [Line Items]
Long-term purchase commitment, amount								2,000,000
Threshold percentage of stock price trigger								85.00%
Volume average price of common stock								100,000
Percentage of stock outstanding								4.99%
Line of credit facility, commitment fee percentage								10.00%
Common stock, shares, issued								82,217,378
Dividends, preferred stock, stock								209,810
Shares To Be Issued [Member] | Common Stock [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues	756,000,000
Stock issued during period, value, new issues	2,341,467
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	16,000,000	16,000,000
Preferred stock, voting rights									2,000
Preferred stock, shares issued	16,000,000	16,000,000							16,000,000
Preferred stock, value, issued	16,000	16,000
Series B Preferred Stock [Member] | Chief Executive Officer [Member]
Class of Stock [Line Items]
Preferred stock, shares issued														16,000,000
Fair market value of preferred stock														2,091,885
Percentage of market capitalization										61.65%
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	5,000	5,000									5,000
Convertible preferred stock conversion price											$0.01
Preferred stock, dividend rate, percentage											8.50%
Preferred stock dividend rate percentage increase											18.00%
Preferred stock dividend paid in stock percentage											85.00%
Preferred stock, shares issued	5,000	0
Preferred stock, value, issued	5										10,000
Common Stock [Member] | Chief Executive Officer [Member]
Class of Stock [Line Items]
Conversion of stock, amount converted	5,000
Compensation expenses	$170,000	$318,333

Related_Party_Transactions_Det

Related Party Transactions (Details Narrative) (USD $)	1 Months Ended
	Nov. 29, 2012	Dec. 31, 2014	Mar. 28, 2013
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Accrued salaries, current		$30,430
Convertible Notes Payable [Member]
Related Party Transaction [Line Items]
Debt instrument, interest rate, effective percentage	3.00%		3.00%
Debt instrument, face amount	$14,000		$9,500
Debt instrument, convertible, conversion price	$0.00		$0.00
Debt instrument, convertible, threshold percentage of stock price trigger	20.00%

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Operating loss carry-forward	$15,570,000	$14,158,000
Tax credit carryforwards, expiration date	2028
Federal Income Tax [Member]
Operating loss carry-forward	$15,570,000

Income_Taxes_Schedule_of_Provi

Income Taxes - Schedule of Provision for Federal Income Tax (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Current operations	$480,009	$419,050
Less: valuation allowance	-480,009	-419,050
Net provision for Federal income taxes

Income_Taxes_Schedule_of_Defer

Income Taxes - Schedule of Deferred Tax Asset (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Net operating loss carryover	$5,293,630	$4,813,621
Valuation allowance	-5,293,630	-4,813,621
Net deferred tax asset

Income_Taxes_Schedule_of_Defer1

Income Taxes - Schedule of Deferred Tax Asset (Details) (Parenthetical)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Percentage of cumulative tax effect at expected rate	34.00%

Restatement_Details_Narrative

Restatement (Details Narrative) (USD $)	12 Months Ended	0 Months Ended
	Dec. 31, 2013	Mar. 01, 2013	Dec. 31, 2014
Percentage of dividends accuring rate	8.50%
Accounts payable and accrued liabilities	$305,680		$670,959
Compensation expense	318,333
Chief Executive Officer [Member] | Series B Preferred Stock [Member]
Stock shares issued during period, shares		16,000,000
Stock shares issued during period amount		2,091,885
Restatement Adjustment [Member]
Accounts payable and accrued liabilities	$126,140

Restatement_Schedule_of_Financ

Restatement - Schedule of Financial Restatements (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounts payable and accrued liabilities	$670,959	$305,680
Total liabilities	961,015	329,180
Preferred stock		23,790
Additional paid in capital	22,094,591	14,991,494
Accumulated deficit	-23,310,033	-16,694,068
Total stockholders' equity (deficit)	-737,533	-75,271	428,629
Stock for services	-254,737	-2,490,218
Interest expense	636,789	126,814
Net loss	-6,615,965	-3,768,859
Basic and diluted loss per share		$0
Weighted average shares outstanding		1,785,586,108
Accounts payable and accrued liabilities	447,779	199,970
Net cash used in operating activities	-722,921	-358,871
Originally Filed [Member]
Accounts payable and accrued liabilities		179,540
Total liabilities		203,040
Preferred stock		7,790
Additional paid in capital		12,597,276
Accumulated deficit		-14,157,710
Total stockholders' equity (deficit)		50,869
Stock for services		80,000
Interest expense		674
Net loss		-1,232,501
Basic and diluted loss per share		$0
Weighted average shares outstanding		2,169,422,459
Accounts payable and accrued liabilities		73,830
Net cash used in operating activities		-358,871
Restatement Adjustment [Member]
Accounts payable and accrued liabilities		126,140
Total liabilities		126,140
Preferred stock		16,000
Additional paid in capital		2,394,218
Accumulated deficit		-2,536,358
Total stockholders' equity (deficit)		-126,140
Stock for services		2,410,218
Interest expense		126,140
Net loss		-2,536,358
Basic and diluted loss per share
Weighted average shares outstanding
Accounts payable and accrued liabilities		126,140
Net cash used in operating activities

Subsequent_Events_Details_Narr

Subsequent Events (Details Narrative) (USD $)	1 Months Ended	12 Months Ended
	Feb. 28, 2014	Dec. 31, 2014	Dec. 31, 2013
Subsequent Event [Member]
Number of stock issued for conversion	66,666,667
Subsequent Event [Member] | Convertible Notes Payable [Member]
Number of stock issued for conversion		831,755,454
Series A2 Convertible Preferred stock [Member]
Proceeds from convertible preferred stock		550,000	$1,100,000
Series A2 Convertible Preferred stock [Member] | Subsequent Event [Member]
Proceeds from convertible preferred stock		100,000
Number of stock issued for conversion		562,941,177
Series A1 Convertible Preferred stock [Member] | Subsequent Event [Member]
Number of stock issued for conversion		251,166,667